Adaptive Biotechnologies Corp
ADPT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001478320
In the last 90 days, Adaptive Biotechnologies Corp insiders filed 0 open-market purchases and 14 sales; 301 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; superinvestors Viking Global Investors and ARK Invest hold it.
13F holders, Q1 2025
Institutional positions in Adaptive Biotechnologies Corp as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 225
- +21 vs. Q4 2024
- Shares held
- 152.9M
- +10.1M (+7.1%) vs. Q4 2024
- Total value
- $1.14B
- +$280.2M (+32.7%) vs. Q4 2024
- New holders
- 40
- 72 more added
- Sold out
- 19
- 68 more reduced
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 301 | $3.34B |
| Q1 2026 | 299 | $2.11B |
| Q4 2025 | 284 | $2.44B |
| Q3 2025 | 271 | $2.18B |
| Q2 2025 | 242 | $1.73B |
| Q1 2025 | 225 | $1.14B |
| Q4 2024 | 207 | $858.6M |
| Q3 2024 | 187 | $732.5M |
| Q2 2024 | 177 | $538.6M |
| Q1 2024 | 190 | $457.4M |
| Q4 2023 | 200 | $704.0M |
| Q3 2023 | 191 | $769.4M |
| Q2 2023 | 210 | $920.9M |
| Q1 2023 | 227 | $1.18B |
| Q4 2022 | 223 | $1.01B |
| Q3 2022 | 226 | $931.2M |
| Q2 2022 | 210 | $1.08B |
| Q1 2022 | 221 | $1.74B |
| Q4 2021 | 214 | $3.46B |
| Q3 2021 | 220 | $4.00B |
| Q2 2021 | 231 | $4.80B |
| Q1 2021 | 249 | $4.58B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Adaptive Biotechnologies Corp; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Standard Life Aberdeen plc | 1,197,622 | $8.90M | 0.02% | +193,563+19.3% | Added |
| Kennedy Capital Management, Inc. | 1,268,574 | $9.43M | 0.23% | +1,268,574 | New |
| Nuveen, LLC | 1,295,117 | $9.62M | 0.00% | +1,295,117 | New |
| Dimensional Fund Advisors LP | 1,424,672 | $10.6M | 0.00% | −180,204−11.2% | Reduced |
| Bank of America Corp | 1,471,553 | $10.9M | 0.00% | +1,230,557+510.6% | Added |
| Victory Capital Management Inc | 1,764,227 | $13.1M | 0.01% | +1,746,571+9,892.2% | Added |
| Goldman Sachs Group Inc | 2,005,444 | $14.9M | 0.00% | −232,682−10.4% | Reduced |
| Voya Investment Management LLC | 2,005,940 | $14.9M | 0.02% | −422,770−17.4% | Reduced |
| Iron Triangle Partners LP | 2,134,061 | $15.9M | 2.50% | +2,134,061 | New |
| Blue Water Life Science Advisors, LLC | 2,145,145 | $15.9M | 15.79% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 2,152,335 | $16.0M | 0.15% | +1,306,164+154.4% | Added |
| Massachusetts Financial Services Co | 2,306,312 | $17.1M | 0.01% | −1,064,607−31.6% | Reduced |
| State Street Corp | 2,689,543 | $20.0M | 0.00% | −40,358−1.5% | Reduced |
| Geode Capital Management, LLC | 2,780,824 | $20.7M | 0.00% | +96,318+3.6% | Added |
| Aristotle Atlantic Partners, LLC | 2,941,212 | $21.9M | 0.74% | +54,510+1.9% | Added |
| Millennium Management LLC | 2,995,301 | $22.3M | 0.02% | −3,297,333−52.4% | Reduced |
| Braidwell LP | 4,803,794 | $35.7M | 1.25% | +4,803,794 | New |
| Nikko Asset Management Americas, Inc. | 6,085,690 | $45.2M | 0.58% | −747,447−10.9% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 6,085,690 | $45.2M | 0.03% | −747,447−10.9% | Reduced |
| Ameriprise Financial Inc | 6,642,476 | $49.4M | 0.01% | +5,905,756+801.6% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 7,732,570 | $57.5M | 0.58% | −1,691,504−17.9% | Reduced |
| Vanguard Group Inc | 11,143,428 | $82.8M | 0.00% | +428,540+4.0% | Added |
| BlackRock, Inc. | 12,229,793 | $90.9M | 0.00% | +108,947+0.9% | Added |
| Rubric Capital Management LP | 13,117,851 | $97.5M | 1.75% | −1,482,149−10.2% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 29,993,708 | $222.9M | 0.71% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −937,331−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −315,098−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −246,865−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −183,838−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −98,357−100.0% | Sold out |
| DDD Partners, LLC | 0 | $0 | 0.00% | −64,747−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −53,170−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −44,069−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −29,585−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −29,093−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −24,500−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −24,469−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −19,078−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −18,585−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −15,732−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −2,522−100.0% | Sold out |
| Archer Investment Corp | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −890−100.0% | Sold out |
| Pacific Capital Wealth Advisors, Inc | 0 | $0 | 0.00% | −390−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Caxton Associates LP | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |